
NTPM
March 3, 2026
PANTOSAN-DSR
March 3, 2026PANTOSAN-40
Pantoprazole Sodium Tablets I.P.
10 x 15 Tablets
Pantosan-40: Comprehensive Product Overview
Pantosan-40, manufactured by Solvista Healthcare, is a high-efficacy pharmaceutical formulation designed for “Advanced Acid Control Therapy.” Categorized as a Proton Pump Inhibitor (PPI), this medication contains Pantoprazole Sodium I.P. (40mg) and is specifically engineered to manage and treat a variety of acid-related gastrointestinal disorders.
Product Composition and Mechanism of Action
The active ingredient in Pantosan-40 is Pantoprazole Sodium. As a Proton Pump Inhibitor, it works by targeting the $H^+/K^+$-ATPase enzyme system (the “proton pump”) located in the parietal cells of the stomach lining. By inhibiting this specific enzyme, Pantosan-40 effectively blocks the final stage of gastric acid production. Unlike antacids, which merely neutralize existing acid, Pantosan-40 prevents acid from being secreted at the source, providing a more robust and long-lasting therapeutic effect.
Key Therapeutic Benefits
Based on the clinical profile presented by Solvista Healthcare, Pantosan-40 offers several distinct advantages for patients:
- Powerful Proton Pump Inhibition: It provides a high level of potency in reducing gastric acid volume, making it superior to older classes of drugs like H2-receptor antagonists.
- Long-Lasting Acid Suppression: A single dose is designed to maintain a stable pH level in the stomach for an extended period, typically covering the patient for a full 24 hours.
- Rapid Relief from Hyperacidity: Patients suffering from acute symptoms of acidity (heartburn, chest pain, and sour eructation) experience swift symptomatic relief.
- Effective GERD Management: It is highly effective in treating Gastroesophageal Reflux Disease (GERD), helping to heal the esophagus and prevent further damage from acid reflux.
Clinical Indications
Pantosan-40 is indicated for a wide range of acid-related conditions, including:
- Gastroesophageal Reflux Disease (GERD): Chronic acid reflux that can lead to erosive esophagitis.
- Peptic Ulcer Disease: Treatment and prevention of gastric and duodenal ulcers.
- Zollinger-Ellison Syndrome: A rare condition where the stomach produces excessive amounts of acid.
- Hypersecretory Conditions: Any state where the body produces more acid than necessary, leading to discomfort or internal damage.
Quality Assurance and Manufacturing
Solvista Healthcare emphasizes a commitment to global standards. Pantosan-40 is produced in WHO-GMP Certified facilities. The “GMP” (Good Manufacturing Practices) certification ensures that the product is consistently produced and controlled according to quality standards. Additionally, the product carries ISO Certification, further validating the company’s dedication to rigorous quality management systems and patient safety.
Packaging and Administration
The product is available in a professional 10 x 15 Tablets blister pack, ensuring a complete course of treatment is easily accessible. Each tablet is formulated to meet the standards of the Indian Pharmacopoeia (I.P.).





Reviews
There are no reviews yet.